ABSTRACT Currently, clinico-pathological staging and classification of residual tumor are the most important prognostic factors for clinical outcome in esophageal cancer. Nevertheless, patients with similar stages of the disease show a marked discrepancy in survival. Several new molecular prognostic factors are being evaluated in the hope that they may contribute to better assessment of the survival probability and, consequently, the ...
Read more